SCHEMBL5229396

SCHEMBL5229396

CC(C)(C)OC(=O)N1CCC2(CCN(c3ccc(N)cc3)C2)C1.CC(C)(C)OC(=O)N1CCC2(CCN(c3ccc(N)cc3F)C2)C1.Cc1cc(N2CCC3(CCN(C(=O)OC(C)(C)C)C3)C2)ccc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.45
HDAC1 Q13547 1/20 0.45
CYP11B2 P19099 1/20 0.43
PARP1 P09874 4/20 0.39
TNKS O95271 2/20 0.39
TNKS2 Q9H2K2 2/20 0.39
ACACB O00763 4/20 0.39
SCD5 Q86SK9 1/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP1A2 P05177 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
HRH3 Q9Y5N1 3/20 0.37
NR1H2 P55055 1/20 0.37
CYP2D6 P10635 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2886408 0.89 CYP11B2 (0.52) HDAC2HDAC1CYP11B2PARP1TNKS
SCHEMBL2884232 0.88 HDAC2 (0.50) HDAC2HDAC1CYP11B2ACACBSCD5
SCHEMBL4299226 0.84 CYP11B2 (0.48) HDAC2HDAC1CYP11B2PARP1TNKS
SCHEMBL25024580 0.84 HDAC2 (0.49) HDAC2HDAC1CYP11B2PARP1TNKS
SCHEMBL4303345 0.83 CYP11B2 (0.52) HDAC2HDAC1CYP11B2ACACBSCD5
SCHEMBL2886266 0.83 CYP11B2 (0.52) HDAC2HDAC1CYP11B2ACACBSCD5
SCHEMBL29772893 0.78 CYP11B2 (0.50) HDAC2HDAC1CYP11B2PARP1TNKS
SCHEMBL24628132 0.78 CYP11B2 (0.50) HDAC2HDAC1CYP11B2PARP1TNKS
SCHEMBL22165053 0.78 NR1H2 (0.46) HDAC2HDAC1CYP11B2PARP1HRH3
SCHEMBL31548466 0.78 NR1H2 (0.46) HDAC2HDAC1CYP11B2PARP1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781663-A2 ARYL-SUBSTITUTED POLYCYCLIC AMINES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT Sanofi-Aventis Deutschland GmbH (DE) 2007-05-09 EP disclosed
WO-2006018280-A2 ARYL-SUBSTITUTED POLYCYCLIC AMINES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-02-23 WO disclosed